Fig. 6From: The accuracy of whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the detection of ovarian cancer relapse in patients with rising cancer antigen 125 (CA-125) levelsA 67-year-old female patient with a history of treated ovarian malignancy (underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy, and received chemotherapy). Her annual CA 125 assessment was found to be elevated up to 2100. Non-contrast-enhanced CT (A) showed multiple enlarged supraclavicular lymph nodes (circled) with avid FDG uptake in the PET (B) and PET/CT (C) images (SUVmax: 4.7) denoting metastatic lymph nodes. Extensive irregular peritoneal thickening was noted wrapping the liver and the spleen in CT image (D) with evident FDG uptake in PET (E) and PET/CT (F) images (SUVmax: 9.5) denoting recurrenceBack to article page